ArticleMolecular cancer therapeutics2023

BET Inhibition Sensitizes Immunologically Cold Rb-Deficient Prostate Cancer to Immune Checkpoint Blockade.

Brian M Olson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.